Inflammation and Hyperbarics

Inflammation is an integral finding in many medical conditions and coincides with nearly all types of injuries and insults to the body. Numerous studies have reported chronic inflammation in:

  • Alzheimer’s
  • Atherosclerosis
  • Autism Spectrum Disorder
  • Cancer
  • Stroke
  • Diabetes
  • Traumatic Brain Injury

Hyperbaric oxygen therapy (HBOT) has been demonstrated to substantially attenuate inflammation throughout the body. HBOT drives increased levels of oxygen into the body, which travels through the plasma, subsequently reducing inflammation and pain. Studies have shown that HBOT increases anti-inflammatory levels and provides increased cellular aid to heal target regions. As oxygen serves as one of the primary mechanisms to ameliorating inflammation, HBOT creates the environment where this process is stimulated and enhanced.

Studies have demonstrated the following benefits of HBOT for inflammation.

Support Anti-Inflammatory Process at the Cellular Level

  • Decreases Acute/Chronic Inflammation • Minimizes Pain & Discomfort
  • Increases Anti-Inflammatory Cytokines • Reduces Swelling
  • Induces Fibroblast Activation

Reduce Neuroinflammation

  •  Ameliorates Autism Symptoms
  • Supports the Prevention & Treatment of Stroke
  • Reduces Risk of Alzheimer’s & Parkinson’s Disease

Decrease Gastrointestinal Inflammation

  • Remediates Inflammatory Bowel Disease
  • Ameliorates Ulcerative Colitis
  • Improves Nutritional Absorption

Relieve Soft Tissue/Joint Inflammation

  • Remediates Osteoarthritis & Rheumatoid Arthritis
  • Ameliorates Tendinitis
  • Accelerates Recovery from Sports-Related & High-Impact Injuries

Prevent the Onset of Chronic Inflammatory-Related Diseases

  • Attenuates Cancer Risk & Progression
  • Reduces Risk of Atherosclerosis, Heart Attack & Stroke
  • Ameliorates Diabetic Conditions Linked to Inflammation

Source: International Hyperbarics Association

Information on this website is provided for educational purposes only. It is not intended as a substitute for the diagnosis, treatment, and advice of a qualified licensed professional. This website offers general information and in no way should anyone consider that this website represents the practice of medicine. This website assumes no responsibility for how this information is used. Also note that this website frequently updates its contents, due to a variety of reasons. No statements or implied treatments on this website have been evaluated or approved by the FDA. It is important that you do not reduce, change, or discontinue any medication or treatment without first consulting your doctor. Please consult your doctor before beginning any new program of treatment.

Study: Atherosclerosis and Inflammation Attenuated with HBOT

A study published in 2007 examined the effects of HBOT for atherosclerosis (plaques of fatty material that line the walls of arteries) with mice. Two groups of mice were treated with either 5 or 10 weeks of HBOT, whereas two other groups remained untreated and were used as a control group. After the introduction of low-density lipoprotein, the treated group exhibited positive changes in the immune/inflammatory response. This represents a critical component of the beneficial effects of HBOT. This study demonstrated that HBOT significantly reduced the circulating levels of low-density lipoprotein that can cause heart disease, kidney disease, and stroke. Additionally, HBOT resulted in a substantial attenuation in the production of pro-inflammatory cytokines in response to an inflammatory stimulus and showed a marked increase in the production of anti-inflammatory cytokine Interleukin 10 by spleen cells. The observed improvements were already noted after only 5 weeks of treatment.

Read the full study: “Chronic hyperbaric oxygen treatment elicits an anti-oxidant response and attenuates atherosclerosis in apoE knockout mice”.